The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Diabetic Gastroparesis: Diagnosis and Management
Abstract
Gastric emptying is frequently abnormal in patients with long-standing type 1 and type 2 diabetes mellitus. Symptoms commonly associated with disordered gastric emptying include nausea, vomiting, bloating and epigastric pain, while patients are also at risk of malnutrition, weight loss, impaired drug absorption, disordered glycaemic control and poor quality of life. Although often attributed to the presence of irreversible autonomic neuropathy, acute hyperglycaemia represents a potentially reversible cause of gastric dysfunction in diabetes. Scintigraphy represents the gold standard for measuring gastric emptying. The management of diabetic gastroparesis is less than optimal, partly because the pathogenesis has not been clearly defined. Treatment approaches include dietary modification and optimization of glycaemia, and the use of prokinetic drugs, while novel therapies such as gastric electrical stimulation are the subject of ongoing investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gastroparesis caused by non-pharmacologic etiologies is indeed known to affect drug absorption [6, 7].”
From Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review (2024) · cites this paper as [7]
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus
Chandalia, M., Garg, A., Lutjohann, D., von Bergmann, K., Grundy, S. M., & Brinkley, L. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421903 · Cited by 1,129
Therapeutic Uses of Botulinum Toxin
Oates, J. A., Wood, A. J. J., Jankovic, J., & Brin, M. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241707 · Cited by 801
Improvement of Gastric Emptying in Diabetic Gastroparesis by Erythromycin: Preliminary Studies
Janssens, J., Peeters, T. L., Vantrappen, G., Tack, J., Urbain, J. L., De Roo, M., Muls, E., & Bouillon, R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221502 · Cited by 753
Parkman, H. P., Hasler, W. L., & Fisher, R. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.055 · Cited by 738 · cited 3×
“Other disorders that result in similar symptoms, including peptic ulcer disease, gastroesophageal reflux disease, gastric cancer, pancreatic or biliary disease, and gastric outlet or mechanical small bowel obstruction,([1]) need to be excluded with appropriate investigations, such as endoscopy and contrast radiology s…”
InfluentialBytzer, P., Talley, N. J., Leemon, M., Young, L. J., Jones, M. P., & Horowitz, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.1989 · Cited by 632 · cited 2×
“The prevalence of gastrointestinal symptoms, such as fullness, postprandial nausea, vomiting, abdominal pain and bloating,([5,6]) is greater in patients with diabetes compared with nondiabetic groups,([55]) although the presence of symptoms correlates poorly with the rate of gastric emptying; only postprandial fullnes…”
Self-citationIntrasphincteric Botulinum Toxin for the Treatment of Achalasia
Pasricha, P. J., Ravich, W. J., Hendrix, T. R., Sostre, S., Jones, B., & Kalloo, A. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321203 · Cited by 556
Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus
Fraser, R. J., Horowitz, M., Maddox, A. F., Harding, P. E., Chatterton, B. E., & Dent, J. (1990) · Diabetologia · doi:10.1007/bf00400569 · Cited by 496
Self-citationOral Erythromycin and the Risk of Sudden Death from Cardiac Causes
Ray, W. A., Murray, K. T., Meredith, S., Narasimhulu, S. S., Hall, K., & Stein, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040582 · Cited by 496
Research works printed but not linked: 16
- Horowitz, 1996, Diabet Med, 13, S16
- Jones, 1995, J Nucl Med, 36, 2220
- Moldovan, 2005, Rom J Gastroenterol, 14, 19
- Phillips, 1992, J Nucl Med, 33, 1496
- Jones, 1996, J Nucl Med, 37, 1643
- Bures, 2005, Cas Lek Cesk, 144, 18
- Chew, 2003, Nucl Med Rev Cent East Eur, 6, 29
- Pfaffenbach, 1995, Z Gastroenterol, 33, 141
- Stevens, 2008, Gastroenterology, 134, A340
- Richards, 1993, Am J Gastroenterol, 88, 203
- Tack, 2001, Gut, 49, 317
- Mansi, 1995, Am J Gastroenterol, 90, 1989
- Lin, 1998, Am J Physiol, 274, G186
- Miller, 2002, Am J Gastroenterol, 97, 1653, 10.1111/j.1572-0241.2002.05823.x · doi:10.1111/j.1572-0241.2002.05823.x · Paper page
- Wang, 2004, J Tradit Chin Med, 24, 163
- Wang, 2007, Zhen Ci Yan Jiu, 32, 199
Cited by
Physical Activity and Type 1 Diabetes: Time for a Rewire?
Colberg, S. R., Laan, R., Dassau, E., & Kerr, D. E. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814566231 · Cited by 189
Management of Diabetes in Pregnancy
Ballas, J., Moore, T. R., & Ramos, G. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0249-0 · Cited by 149
Freeman, R. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00006-0 · Cited by 160
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research · doi:10.1155/2011/279530 · Cited by 138
Self-citationVinik, A. I., & Erbas, T. A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00022-5 · Cited by 166
Metadata
- Authors
- Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M.
- Affiliations
- Royal Adelaide Hospital (AU)
- Corresponding author
- Rayner, Christopher K.
- Venue
- Drugs
- Published
- 2009-06
- Volume
- 69
- Issue
- 8
- Pages
- 971-986
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W2044461733
- Cited by
- 87
- References
- 174
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2021: 2 · 2020: 8 · 2019: 8 · 2018: 4 · 2017: 3 · 2016: 1 · 2015: 7 · 2014: 8 · 2013: 3 · 2012: 6
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drugs (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Royal Adelaide Hospital
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic gastroparesis, gastric emptying disorders, type 1 diabetes, type 2 diabetes, autonomic neuropathy, acute hyperglycaemia, scintigraphy, prokinetic drugs, gastric electrical stimulation, dietary change, glycemic control, malnutrition, drug absorption
- MeSH terms
- Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Gastric Emptying, Humans, Hyperglycemia, Radionuclide Imaging, Prevalence, Gastroparesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetic Gastroparesis: Diagnosis and Management. https://app.cochat.ai/papers/10.2165/00003495-200969080-00003
- The paper
- Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009). Diabetic Gastroparesis: Diagnosis and Management. Drugs. https://doi.org/10.2165/00003495-200969080-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.